back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-05-07 10:50 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,877
+1,010 vol $11.76 each |
51,620 | |
| Filed 2026-05-07 10:43 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,884 vol |
62,504 | |
| Filed 2026-03-26 16:15 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,844 vol |
||
| Filed 2026-03-26 16:12 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,313
+877 vol $11.76 each |
||
| Filed 2026-05-06 17:07 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,918
-9,800 vol $0.91 each |
34,596 | |
| Filed 2026-05-06 16:55 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-20,201 vol |
48,463 | |
| Filed 2026-05-06 16:50 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,862 vol |
||
| Filed 2026-05-06 16:19 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+17,103 vol |
52,017 | |
| Filed 2026-05-06 16:18 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,510 vol |
52,411 | |
| Filed 2026-05-06 16:14 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-15,940 vol |
50,610 | |
| Filed 2026-05-06 16:13 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+13,582 vol |
66,550 | |
| Filed 2026-05-06 16:11 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
+951 vol |
52,968 | |
| Filed 2026-05-06 16:10 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-18,661 vol |
34,914 | |
| Filed 2026-05-06 16:09 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,164 vol |
53,575 | |
| Filed 2026-05-06 16:07 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-31,862 vol |
||
| Filed 2026-05-06 16:06 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+19,147 vol |
83,921 | |
| Filed 2026-05-06 16:05 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+15,182 vol |
64,774 | |
| Filed 2026-05-06 16:04 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+18,082 vol |
49,592 | |
| Filed 2026-05-06 16:03 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+31,510 vol |
31,510 | |
| Filed 2026-05-06 15:58 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,268
+8,375 vol $4.45 each |
591,303 | |
| Filed 2026-05-06 15:56 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-11,338.90
-1,522 vol $7.45 each |
65,970 | |
| Filed 2026-05-06 15:56 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-781.00
-100 vol $7.81 each |
582,928 | |
| Filed 2026-05-06 15:55 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,545
-8,275 vol $7.80 each |
583,028 | |
| Filed 2026-05-06 15:53 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-37,268.75
-8,375 vol $4.45 each |
55,556 | |
| Filed 2026-05-06 15:52 Tx date 2016-12-02 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
||
| Filed 2026-05-06 15:52 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-3,300
-30,000 vol $0.11 each |
324,209 | |
| Filed 2026-05-06 15:51 Tx date 2014-02-03 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-10,000
-100,000 vol $0.10 each |
348,175 | |
| Filed 2026-05-06 15:50 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
52 - Expiration of options
|
$-49,496.64
-4,512 vol $10.97 each |
61,458 | |
| Filed 2026-05-06 15:49 Tx date 2014-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$11,338
+1,522 vol $7.45 each |
349,697 | |
| Filed 2026-05-06 15:44 Tx date 2024-06-13 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,338
+1,522 vol $7.45 each |
631,530 | |
| Filed 2026-05-06 14:43 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-20,201 vol |
||
| Filed 2026-05-06 14:43 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$88,865
+7,970 vol $11.15 each |
640,108 | |
| Filed 2026-05-06 14:42 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-15,940 vol |
||
| Filed 2026-05-06 14:41 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+13,582 vol |
||
| Filed 2026-05-06 14:41 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,454
+951 vol $8.89 each |
||
| Filed 2026-05-06 14:40 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-18,661 vol |
||
| Filed 2026-05-06 14:40 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,974
+1,164 vol $7.71 each |
||
| Filed 2026-05-06 14:38 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,931 vol |
619,575 | |
| Filed 2026-05-06 14:35 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+19,147 vol |
||
| Filed 2026-05-06 14:34 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$138,004
+15,182 vol $9.09 each |
||
| Filed 2026-05-06 14:33 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$131,998
+18,082 vol $7.30 each |
||
| Filed 2026-05-06 14:33 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$113,751
+31,510 vol $3.61 each |
||
| Filed 2026-05-06 13:51 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
957,500 | |
| Filed 2026-04-02 09:44 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-20,201 vol |
||
| Filed 2026-04-02 09:42 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-88,865.50
-7,970 vol $11.15 each |
||
| Filed 2026-04-02 09:41 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-15,940 vol |
||
| Filed 2026-04-02 09:34 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-31,862 vol |
||
| Filed 2025-04-04 16:27 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$88,865
+7,970 vol $11.15 each |
||
| Filed 2025-04-04 16:25 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,940 vol |
||
| Filed 2025-04-04 16:22 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+13,582 vol |
||
| Filed 2025-04-04 16:17 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,454
+951 vol $8.89 each |
||
| Filed 2024-06-17 18:41 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$11,338
+1,522 vol $7.45 each |
||
| Filed 2024-04-02 18:34 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-18,661 vol |
||
| Filed 2024-04-02 18:28 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,974
+1,164 vol $7.71 each |
||
| Filed 2023-04-05 17:55 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+19,147 vol |
||
| Filed 2022-04-04 11:25 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$138,004
+15,182 vol $9.09 each |
||
| Filed 2021-03-24 17:28 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$131,998
+18,082 vol $7.30 each |
||
| Filed 2020-04-02 12:58 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$113,751
+31,510 vol $3.61 each |
||
| Filed 2018-12-21 17:58 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-781.00
-100 vol $7.81 each |
||
| Filed 2018-12-21 17:58 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-64,545
-8,275 vol $7.80 each |
||
| Filed 2018-12-21 17:49 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$37,268
+8,375 vol $4.45 each |
||
| Filed 2017-12-23 16:02 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$8,918
+9,800 vol $0.91 each |
||
| Filed 2016-12-12 17:32 Tx date 2016-12-02 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
||
| Filed 2016-01-20 18:28 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$33,000
+300,000 vol $0.11 each |
||
| Filed 2015-08-31 18:42 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,300
+30,000 vol $0.11 each |
||
| Filed 2014-02-07 16:10 Tx date 2014-02-03 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2026-04-10 16:25 Tx date 2026-03-25 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+6,333 vol |
18,054 | |
| Filed 2026-03-26 16:14 Tx date 2026-03-01 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+6,333 vol |
||
| Filed 2026-04-07 15:55 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,591
+366 vol $7.08 each |
||
| Filed 2026-04-07 15:54 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+17,103 vol |
||
| Filed 2024-04-02 18:36 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+17,103 vol |
||
| Filed 2023-03-31 18:02 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,591
+366 vol $7.08 each |
||
| Filed 2026-04-02 09:45 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$145,642
+10,100 vol $14.42 each |
651,219 | |
| Filed 2026-04-02 09:44 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-20,201 vol |
641,119 | |
| Filed 2026-04-02 09:42 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-88,865.50
-7,970 vol $11.15 each |
658,861 | |
| Filed 2026-04-02 09:41 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-15,940 vol |
666,831 | |
| Filed 2026-04-02 09:34 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-31,862 vol |
656,069 | |
| Filed 2025-04-04 16:27 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$88,865
+7,970 vol $11.15 each |
||
| Filed 2025-04-04 16:25 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,940 vol |
||
| Filed 2026-03-26 16:15 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,844 vol |
18,054 | |
| Filed 2026-03-26 16:14 Tx date 2026-03-01 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+6,333 vol |
7,210 | |
| Filed 2026-03-26 16:12 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,313
+877 vol $11.76 each |
877 | |
| Filed 2026-03-26 16:08 Tx date 1996-01-04 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-26 16:07 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$28,548
+2,459 vol $11.61 each |
741,002 | |
| Filed 2026-03-26 15:58 Tx date 2016-12-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-2,400,000
-300,000 vol $8.00 each |
657,500 | |
| Filed 2026-03-26 15:52 Tx date 2002-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aquiam Partners Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+500,000 vol |
500,000 | |
| Filed 2026-03-26 15:48 Tx date 1996-01-04 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aquiam Partners Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-12 17:34 Tx date 2016-12-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$-2,400,000
-300,000 vol $8.00 each |
||
| Filed 2025-04-04 16:27 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$88,865
+7,970 vol $11.15 each |
1,038,543 | |
| Filed 2025-04-04 16:25 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,940 vol |
1,030,573 | |
| Filed 2025-04-04 16:22 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+13,582 vol |
1,014,633 | |
| Filed 2025-04-04 16:17 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,454
+951 vol $8.89 each |
1,001,051 | |
| Filed 2025-04-04 16:15 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,937
+2,130 vol $9.83 each |
1,000,100 | |
| Filed 2024-06-17 18:46 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,276.36
-1,522 vol $9.38 each |
997,970 | |
| Filed 2024-06-17 18:41 Tx date 2024-06-12 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$11,338
+1,522 vol $7.45 each |
335,867 | |
| Filed 2024-04-02 18:36 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+17,103 vol |
999,492 | |
| Filed 2024-04-02 18:35 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$79,305
+9,330 vol $8.50 each |
982,389 | |
| Filed 2024-04-02 18:34 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-18,661 vol |
973,059 | |
| Filed 2024-04-02 18:28 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,974
+1,164 vol $7.71 each |
991,720 | |
| Filed 2024-04-02 18:27 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,343
+2,625 vol $7.75 each |
990,556 | |
| Filed 2023-04-05 17:55 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+19,147 vol |
987,931 | |
| Filed 2023-03-31 18:02 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,591
+366 vol $7.08 each |
968,784 | |
| Filed 2023-03-31 17:59 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,757
+2,074 vol $8.08 each |
968,418 | |
| Filed 2022-04-04 11:25 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$138,004
+15,182 vol $9.09 each |
966,344 | |
| Filed 2022-03-24 15:03 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,688
+1,516 vol $7.71 each |
951,162 | |
| Filed 2021-03-24 17:28 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$131,998
+18,082 vol $7.30 each |
949,646 | |
| Filed 2021-03-24 17:26 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,357
+1,063 vol $5.04 each |
931,564 | |
| Filed 2020-04-02 12:58 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$113,751
+31,510 vol $3.61 each |
930,501 | |
| Filed 2020-03-31 18:26 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,400
+4,000 vol $3.60 each |
898,991 | |
| Filed 2020-03-31 18:21 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,495
+2,114 vol $7.33 each |
894,991 | |
| Filed 2019-03-27 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,000
+1,574 vol $9.53 each |
892,877 | |
| Filed 2019-03-24 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$98,113
+11,936 vol $8.22 each |
334,345 | |
| Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-64,545
-8,275 vol $7.80 each |
322,509 | |
| Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$37,268
+8,375 vol $4.45 each |
330,784 | |
| Filed 2018-12-21 Tx date 2018-12-21 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-781.00
-100 vol $7.81 each |
322,409 | |
| Filed 2018-09-12 Tx date 2018-09-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-345,600
-36,000 vol $9.60 each |
891,303 | |
| Filed 2018-09-12 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,825
-500 vol $9.65 each |
968,155 | |
| Filed 2018-09-12 Tx date 2018-09-07 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-169,035
-17,700 vol $9.55 each |
968,655 | |
| Filed 2018-09-12 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-392,179.20
-40,852 vol $9.60 each |
927,303 | |
| Filed 2018-03-27 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,995
+1,562 vol $8.96 each |
986,355 | |
| Filed 2018-01-12 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$93,456
+9,735 vol $9.60 each |
322,409 | |
| Filed 2017-12-23 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$96,725
+9,800 vol $9.87 each |
984,793 | |
| Filed 2017-12-23 Tx date 2017-12-18 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$8,918
+9,800 vol $0.91 each |
312,674 | |
| Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$139,944
+17,493 vol $8.00 each |
974,993 | |
| Filed 2017-03-18 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$85,480
+11,630 vol $7.35 each |
302,874 | |
| Filed 2016-12-12 Tx date 2016-12-02 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
591,244 | |
| Filed 2016-12-12 Tx date 2016-12-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$-2,400,000
-300,000 vol $8.00 each |
291,244 | |
| Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$53,053
+8,557 vol $6.20 each |
291,244 | |
| Filed 2016-01-21 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
||
| Filed 2016-01-21 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-33,000
-300,000 vol $0.11 each |
282,687 | |
| Filed 2016-01-20 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$33,000
+300,000 vol $0.11 each |
957,500 | |
| Filed 2016-01-18 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$33,000
+300,000 vol $0.11 each |
882,687 | |
| Filed 2015-08-31 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,300
+30,000 vol $0.11 each |
657,500 | |
| Filed 2015-08-31 Tx date 2015-08-24 |
$RX
BioSyent Inc. |
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,300
+30,000 vol $0.11 each |
582,687 |